Sorry people - and maybe II do not read this right.
Getting FDA "guidance" on the design of the phase 2 trial is not approval for FDA fast tracking. I cannot see FDA fast track approval in the announcement.
From my experience, "guidance" simply means that a trial is judged to be OK or not OK.
